Detection of glycopeptide-resistant enterococci in routine diagnostic faeces specimens

Journal of Hospital Infection

Volumn 43, Issue 1, 1999, Pages 25-32

  Taylor, M E ^a   Oppenheim, B A ^a   Chadwick, P R ^b   Weston, D ^a   Palepou, M Fl ^c   Woodford, N ^c   Bellis, M ^d  

^a WITHINGTON HOSPITAL   (United Kingdom)

^b HOPE HOSPITAL   (United Kingdom)

^c CENTRAL PUBLIC HEALTH LABORATORY   (United Kingdom)

^d LIVERPOOL JOHN MOORES UNIVERSITY   (United Kingdom)

Author keywords

Colonization; Enterococci; Faeces; Glycopeptide resistance; Glycopeptide resistant enterococci

Indexed keywords

GLYCOPEPTIDE;

ADOLESCENT; ADULT; AGED; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL INFECTION; CHILD; CLOSTRIDIUM DIFFICILE; COMMUNITY; DEVICE; DRUG RESISTANCE; ENTEROCOCCUS; FECES ANALYSIS; GENERAL PRACTICE; HOSPITALIZATION; HUMAN; INFANT; MAJOR CLINICAL STUDY; METHODOLOGY; PHENOTYPE;

EID: 0032837140     PISSN: 01956701     EISSN: None     Source Type: Journal    
DOI: 10.1053/jhin.1999.0630     Document Type: Article

References (54)

1. Uttley AH, George RC, Naidoo J et al. High-level vancomycin-resistant enterococci causing hospital infections. Epidemiol Infect 1989; 103: 173-181.
2. Sahm DF, Kissinger J, Gilmore JS et al. In vitro susceptibility studies of vancomycin resistant Enterococcus faecalis. Antimicrob Agents Chemother 1989; 33: 1588-1591.
3. Woodford N. Glycopeptide-resistant enterococci: a decade of experience. J Med Microbiol 1998; 47: 849-62.
4. French GL. Enterococci and vancomycin resistance. Clin Infect Dis 1998; 27(Suppl 1): S75-83.
5. Moellering RC Jr. Vancomycin-resistant enterococci. Clin Infect Dis 1998; 26: 1196-9.
6. Moellering RC Jr. The specter of glycopeptide resistance: current trends and future considerations. Am J Med 1998; 104: 3S-6S.
7. Woodford N, Johnson AP, Morrison D, Speller DCE. Current perspectives on glycopeptide resistance. Clin Micro Rev 1995; 8: 585-615.
8. Sanyal D, Williams AJ, Johnson AP, George RC. The emergence of vancomycin resistance in renal dialysis. J Hosp Infect 1993; 24: 167-173.
9. Karanfil LV, Murphy M, Josephson A et al. A cluster of vancomycin-resistant Enterococcus faecium in an intensive care unit. Infect Control Hosp Epidemiol 1992; 13: 195-200.
10. Moreno F, Grota P, Crisp C et al. Clinical and molecular epidemiology of vancomycin-resistant Enterococcus faecium during its emergence in a city in southern Texas. Clin Infect Dis 1995; 21: 1234-1237.
11. Frieden TR, Munsiff SS, Low DE et al. Emergence of vancomycin-resistant enterococci in New York City. Lancet 1993; 342: 76-79.
12. Handwerger S, Raucher B, Altarac D et al. Nosocomial outbreak due to Enterococcus faecium highly resistant to vancomycin, penicillin, and gentamicin. Clin Infect Dis 1993; 16: 750-755.
13. Wade JJ. The emergence of Enterococcus faecium resistant to glycopeptides and other standard agents - a preliminary report. J Hosp Infect 1995; 30(Suppl): 483-493.
14. Rubin LG, Tucci V, Cercenado E, Eliopoulos G, Isenberg HD. Vancomycin-resistant Enterococcus faecium in hospitalized children. Infect Control Hosp Epidemiol 1992; 13: 700-705.
15. Morris JG Jr, Shay DK, Hebden JN et al. Enterococci resistant to multiple antimicrobial agents, including vancomycin. Establishment of endemicity in a university medical center. Ann Intern Med 1995; 123: 250-259.
16. Boyle JF, Soumakis SA, Rendo A et al. Epidemiological analysis and genotypic characterization of a nosocomial outbreak of vancomycin-resistant enterococci. J Clin Microbiol 1993; 31: 1280-1285.
17. Manso E, De Sio G, Biavasco F, Varaldo PE, Sambo G, Maffei C. Vancomycin-resistant enterococci. Lancet 1993; 342: 616-617.
18. Boyce JM, Opal SM, Chow JW et al. Outbreak of multidrug-resistant Enterococcus faecium with transferable vanB class vancomycin resistance. J Clin Microbiol 1994; 32: 1148-1153.
19. Henning KJ, Delencastre H, Eagan J et al. Vancomycin-resistant Enterococcus faecium on a pediatric oncology ward: duration of stool shedding and incidence of clinical infection. Pediatr Infect Dis J 1996; 15: 848-854.
20. Montecalvo MA, de Lencastre H, Carraher M et al. Natural history of colonization with vancomycin-resistant Enterococcus faecium. Infect Control Hosp Epidemiol 1995; 16: 680-685.
21. Bates J. Epidemiology of vancomycin-resistant enterococci in the community and the relevance of farm animals to human infection. J Hosp Infect 1997; 37: 89-101.
22. Jordens JZ, Bates J, Griffiths DT Faecal carriage and nosocomial spread of vancomycin-resistant Enterococcus faecium. J Antimicrob Chemother 1994; 34: 515-528.
23. Klare I, Heier H, Claus G et al. Enterococcus faecium strains with vanA mediated high level resistance isolated from animal foodstuffs and fecal samples of humans in the community. Microb Drug Res 1995a; 1: 265-272.
24. Van der Auwera P, Pensart N, Korten V, Murray BE, Leclercq R. Incidence of oral glycopeptides on the fecal flora of human volunteers: selection of highly glycopeptide resistant enterococci. J Infect Dis 1996; 173: 1129-1136.
25. Weinstein JW, Roe M, Towns M et al. Resistant enterococci: a prospective study of prevalence, incidence, and factors associated with colonization in a university hospital. Infect Control Hosp Epidemiol 1996; 17: 36-41.
26. Archibald L, Phillips L, Monnet D, McGowan JE Jr, Tenover F, Gaynes R. Antimicrobial resistance in isolates from inpatients and outpatients in the United States: increasing importance of the intensive care unit. Clin Infect Dis 1997; 24: 211-215.
27. Torres C, Reguera JA, Sanmartin MJ, Perez-Diaz JC, Baquero F. VanA-mediated vancomycin-resistant Enterococcus spp. in sewage. J Antimicrob Chemother 1994; 33: 553-561.
28. Klare I, Heier H, Claus G, Witte W. Environmental strains of Enterococcus faecium with inducible high-level resistance to glycopeptides. FEMS Microbiol Lett 1993; 106: 23-30.
29. Bates J, Jordens JZ, Griffiths DT Farm animals as a putative reservoir for vancomycin-resistant enterococcal infection in man. J Antimicrob Chemother 1994; 34: 507-516.
30. Devriese LA, Ieven M, Goossens H et al. Presence of vancomycin-resistant enterococci in farm and pet animals. Antimicrob Agents Chemother 1996; 40: 2285-2287.
31. van Belkun A, van den Braak N, Thomassen R, Verbrugh H, Endtz H. Vancomycin-resistant enterococci in cats and dogs. Lancet 1996; 348: 1038-1039.
32. Aarestrup FM. Occurrence of glycopeptide resistance among Enterococcus faecium isolates from conventional and ecological poultry farms. Microb Drug Res 1995; 1: 255-257.
33. Chadwick PR, Woodford N, Kaczmarski EB, Gray S, Barrel RA, Oppenheim BA. Glycopeptide-resistant enterococci isolated from uncooked meat. J Antimicrob Chemother 1996; 38: 908-909.
34. Klare I, Heier H, Claus G, Reissbrodt R, Witte W. VanA-mediated high level glycopeptide resistance in Enterococcus faecium from animal husbandry. FEMS Microbiol Lett 1995b; 125: 165-172.
35. Coque T M, Tomayko J F, Ricke S C, Okhyusen P C, Murray B E. Vancomycin-resistant enterococci from nosocomial, community, and animal sources in the United States. Antimicrob Agents Chemother 1996; 40: 2605-2609.
36. Thai L A, Chow J W, Mahayni R et al. Characterization of antimicrobial resistance in enterococci of animal origin. Antimicrob Agents Chemother 1995; 39: 2112-2115.
37. Knudtson L M, Hartman P A. Antibiotic resistance among enterococcal isolates from environmental and clinical sources. J Food Prot 1993; 56: 489-492.
38. Dunne W M. Watch out where the huskies go. ASM News 1996; 62: 283.
39. Kirst H A, Thompson D G, Nicas T I. Historical yearly usage of vancomycin. Antimicrob Agents Chemother 1998; 42: 1303-4.
40. Rao G G, Ghanekar K, Ojo F. Selective medium for vancomycin-resistant enterococci in faeces. Eur J Clin Microbiol Infect Dis 1996; 15: 175-177.
41. British Society for Antimicrobial Chemotherapy. A guide to sensitivity testing. J Antimicrob Chemother 1991; 27: Suppl D.
42. Woodford N, Morrison D, Johnson AP et al. Plasmid mediated VanB glycopeptide resitance in enterococci. Microb Drug Resist 1995; 1: 235-40.
43. Chadwick P R, Oppenheim B A. Controlling glycopeptide-resistant enterococci. Clin Microbiol Infect 1997; 3: 7-11.
44. Chadwick P R, Brown D F J, Wilcox M H et al. Comparison of agar-based media for primary isolation of glycopeptide-resistant enterococci. Clin Microbiol Infect 1997; 3: 559-563.
45. Nelson R R. Selective isolation of vancomycin-resistant enterococci. J Hosp Infect 1998; 39: 13-8.
46. Landman D, Quale J M, Oydna E et al. Comparison of five selective media for identifying fecal carriage of vancomycin-resistant enterococci. Clin Microbiol 1996; 34: 751-752.
47. Van Horn K G, Gedris C A, Rodney K M. Selective isolation of vancomycin-resistant enterococci. J Clin Microbiol 1996; 34: 924-27.
48. Edberg S C, Hardalo C J, Kontnick C, Campbell S. Rapid detection of vancomycin-resistant enterococci. J Clin Microbiol 1994; 32: 2182-2184.
49. Flournoy D J. Antimicrobial susceptibilities of bacteria from nursing home residents in Oklahoma. Gerontology 1994; 40: 53-56.
50. Frankel D H. Resistant enterococci in California. Lancet 1994; 343: 1560.
51. Lam S, Singer C, Tucci V, Morthland VH, Pfaller MA, Isenberg HD. The challenge of vancomycin-resistant enterococci: a clinical and epidemiologic study. Am J Infect Control 1995; 23: 170-180.
52. Noble W C, Virani Z, Cree R. Cotransfer of vancomycin and other resistance genes from Enterococcus faecalis NCTC 12201 to Staphylococcus aureus. FEMS Microbiol Lett 1992; 93: 195-198.
53. Chadwick P R, Oppenheim B A, Fox A, Woodford N, Morgenstern G R, Scarffe J H. Epidemiology of an outbreak due to glycopeptide-resistant Enterococcus faecium on a leukaemia unit. J Hosp Infect 1996; 34: 171-182.
54. Bell J M, Paton J C, Turnidge J. Emergence of vancomycin-resistant enterococci in Australia: phenotypic and genotypic characteristics of isolates. J Clin Microbiol 1998; 36: 2187-90.